Dr Alan Mawson

Alan Mawson is a venture capital fund manager, the Founder and now Non-executive Chairman of Clarendon Fund Managers Limited (“Clarendon”). He was an initial director of the General Partner of the Rainbow Seed Fund, now a £24 million fund, set up to commercialise technology arising from the UK public sector research laboratories, and of other fund management companies. A Master of Science of the Sloan School, MIT, Cambridge, Mass., a former consultant with McKinsey & Co, Director of Research at Wiggins Teape and Chair of Council of the University of Salford, Alan, an organic and polymer research chemist, joined the Fusion Antibodies as a Director in 2004 as a representative of Clarendon.